Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin with Idarubicin and Cytarabine in Poor-Risk AML
NCT00840177Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Dec 2009
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pravastatin in acute myeloid leukemia (AML), sponsored by SWOG Cancer Research Network. Started Dec 2009; status: completed.
02
Drugs
pravastatin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00840177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00840177.